High-dose-rate brachytherapy in early oral cancer with close or positive margins

Brachytherapy

Volumn 14, Issue 1, 2015, Pages 77-83

  Petera, Jiří ^a   Sirák, Igor ^a   Laco, Jan ^a   Kašaová, Linda ^a   Tuček, Luboš ^a   Doležalová, Helena ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

High dose rate brachytherapy; Locoregional control; Oral cancer; Prognostic factors; VEGF

Indexed keywords

VASCULOTROPIN; TUMOR MARKER; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BONE NECROSIS; BRACHYTHERAPY; BRACHYTHERAPY BALLOON CATHETER; BRACHYTHERAPY IMPLANT; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; NECK DISSECTION; OVERALL SURVIVAL; RADIATION INJURY; RADIATION NECROSIS; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; SOFT TISSUE NECROSIS; SURGICAL ANATOMY; ULCER; EVALUATION STUDY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; SALVAGE THERAPY; TUMOR INVASION;

ADULT; AGED; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919674625     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2014.08.050     Document Type: Article

References (27)

1. Whitehurst J.O., Droulias C.A. Surgical treatment of squamous cell carcinoma of the oral tongue: Factors influencing survival. Arch Otolaryngol 1977, 103:212-215.
2. Spiro R., Strong E.W. Epidermoid carcinoma of the mobile tongue. Treatment by partial glosectomy alone. Am J Surg 1971, 122:707-710.
3. Hung S.H., O'Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 2013, 18:233-240.
4. Mazeron I.J., Crook J.M., Benck V., et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990, 19:1369-1376.
5. Dearnaley D.P., Dardoufas C., ÁHearn R.P., Henk J.M. Interstitial irradiation for carcinoma of the tongue and floor of mouth. Royal Marsden Hospital Experience 1970-1986. Radiother Oncol 1991, 21:183-192.
6. Grabenbauer G.G., Rödel C., Brunner T., et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Strahlenther Onkol 2001, 177:338-344.
7. Mazeron J.J., Ardiet J.M., Haie-Méder C., et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009, 91:150-156.
8. Strnad V. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 2004, 180:710-717.
9. Umeda M., Komatsubara H., Nishimatsu N., et al. High-dose rate interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 90:667-670.
10. Lau H.Y., Hay J.H., Flores A.D., Threlfall W.J. Seven fractions of twice daily high-dose rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996, 39:15-18.
11. Inoue T., Inoue T., Yoshida K., et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 2001, 51:171-175.
12. Yamazaki H., Inoue T., Yoshida K., et al. Brachytherapy for early oral tongue cancer: Low dose rate to high dose rate. J Radiat Res 2003, 44:37-40.
13. Guinot J.L., Santos M., Tortajada M.I., et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy 2010, 9:227-234.
14. Petera J., Sirak I., Tucek L., et al. Predicting factors for locoregional failure of high-dose-rate brachytherapy for early-stage oral cancer. Personalized Med 2012, 9:879-887.
15. Nag S., Cano E.R., Demanses D.J., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 2001, 50:1190-1198.
16. Liu Z., Huang S., Zhang D. High does rate versus low dose rate brachytherapy for oral cancer - a meta-analysis of clinical trials. PLoS One 2013, 8:1-6.
17. Akiyama H., Yoshida K., Yamazaki H., et al. High dose rate interstitial brachytherapy for mobile tongue cancer: Preliminary results of a dose reduction trial. J Contemp Brachytherapy 2014, 6:10-14.
18. Lapeyre M., Hoffstetter S., Peiffert D., et al. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 2000, 48:37-42.
19. Fujita M., Hirokawa Y., Kashiwado K., et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: Factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 1999, 44:767-775.
20. El-Naaj I.A., Leiser Y., Shveis M., et al. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg 2011, 69:2674-2679.
21. Nakagawa T., Shibuya H., Yoshimura R., et al. Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol 2003, 68:129-135.
22. Matsumoto K., Sasaki T., Shioyama Y., et al. Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer. Jpn J Clin Oncol 2013, 43:1012-1017.
23. Tuček L., Petera J., Sirák I., et al. Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer. Rep Pract Oncol Radiother 2011, 16:243-247.
24. Ganly I., Goldstein D., Carlson D.L., et al. Long-term regional control and survival in patients with "low risk" early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: The importance of tumor thickness. Cancer 2013, 119:1168-1176.
25. Sugiura T., Inoue Y., Matsuki R., et al. VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. Int J Oncol 2009, 34:673-680.
26. Shang Z.J., Li J.R., Li Z.B. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma. J Oral Maxillofac Surg 2007, 65:17-21.
27. Seki S., Fujiwara M., Matsuura M., et al. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors. Oral Oncol 2011, 47:588-593.